SCHEMBL31542160

SCHEMBL31542160

CCC(C(=O)N1Cc2ccc(-c3ccccc3C(=O)O)cc2C1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.51
▸ TSHR P16473 3/20 0.51
▸ KDM4E B2RXH2 2/20 0.51
▸ HSD17B10 Q99714 1/20 0.51
▸ GAA P10253 1/20 0.44
▸ PPARG P37231 5/20 0.43
▸ PPARA Q07869 2/20 0.43
▸ LMNA P02545 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ DPP8 Q6V1X1 3/20 0.41
▸ DPP9 Q86TI2 3/20 0.41
▸ DPP7 Q9UHL4 3/20 0.41
▸ DPP4 P27487 1/20 0.41
▸ PTPN11 Q06124 1/20 0.41
▸ ADORA1 P30542 1/20 0.41
▸ HTR1A P08908 1/20 0.40
▸ ADRA1A P35348 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31432714 1.00 ALDH1A1 (0.51) ALDH1A1TSHRKDM4EHSD17B10GAA
SCHEMBL31432763 1.00 ALDH1A1 (0.51) ALDH1A1TSHRKDM4EHSD17B10GAA
SCHEMBL31432781 0.89 ALDH1A1 (0.53) ALDH1A1TSHRKDM4EHSD17B10GAA
SCHEMBL31432883 0.89 ALDH1A1 (0.53) ALDH1A1TSHRKDM4EHSD17B10GAA
SCHEMBL31432712 0.88 NAMPT (0.43) LMNAL3MBTL1DPP8DPP9DPP7
SCHEMBL31432759 0.87 DPP7 (0.44) L3MBTL1DPP8DPP9DPP7DPP4
SCHEMBL31432718 0.87 DPP7 (0.44) L3MBTL1DPP8DPP9DPP7DPP4
SCHEMBL31542161 0.87 DPP7 (0.44) L3MBTL1DPP8DPP9DPP7DPP4
SCHEMBL31432853 0.81 POLB (0.46) ALDH1A1PPARG
SCHEMBL31432838 0.78 DPP8 (0.62) ALDH1A1TSHRKDM4EHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025088073-A1 HETEROCYCLIC COMPOUNDS AS BLT2 AGONISTS AND THEIR MEDICAL USE Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2025-05-01 — — WO disclosed
Send feedback